Tactile Systems Technology, Inc. TCMD
TCMD Rating
TCMD Rating Factors
TCMD Company Overview
Tactile Systems Technology, Inc. (NASDAQ: TCMD), commonly known as Tactile Medical, is a U.S.-based medical technology company focused on developing and commercializing medical devices for chronic disease management in the home setting. The company primarily operates in the durable medical equipment and medical device industries, with a concentration on therapies for lymphedema, chronic venous insufficiency, and pulmonary conditions associated with retained secretions. Its core products are designed to support long-term patient care outside of acute clinical environments, with reimbursement support from Medicare, Veterans Affairs programs, and commercial insurers.
The company’s principal revenue drivers include its proprietary pneumatic compression systems and airway clearance devices. Its flagship products include the Flexitouch system for lymphedema treatment, the Entre system for edema management, and the AffloVest system for airway clearance therapy. Tactile Medical primarily serves patients with chronic conditions, healthcare providers, clinics, and integrated delivery networks across the United States. The company differentiates itself through a clinically focused sales model, reimbursement expertise, and direct patient support infrastructure. Founded in 1995 and headquartered in Minnesota, the company evolved from a niche compression therapy provider into a broader chronic disease management platform through internal product development and acquisitions, including the acquisition of AffloVest assets to expand into respiratory therapy.
TCMD Income Statement
TCMD Balance Sheet
TCMD Price History
TCMD Valuation
TCMD Dividends and Shares
TCMD Corporate Info
Suite 300
Minneapolis, MN 55416